Clinical Trial

Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life

Study acronym: PanFit
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to measure hand grip strength in adults with pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are: * Is it feasible to measure hand grip strength as part of a clinic visit? * Are changes in hand grip strength related to changes in body composition? * Is hand grip strength related to a person's well-being? * Is hand grip strength related to how a tumour responds to treatment? Participants will squeeze a device with their hand to measure their hand grip strength and complete questionnaires about their well-being when they are seen in clinic for their regular medical care for PDAC.
Trial Details
NCT Number NCT07255001
Lead Sponsor British Columbia Cancer Agency
Conditions Pancreatic Ductal Adenocarcinoma (PDAC), Hand Grip Strength
Enrollment 50 participants
Start Date 2025-12
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-28